ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BBAL New York Health Care Inc (CE)

0.0001
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
New York Health Care Inc (CE) USOTC:BBAL OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0001 0.00 01:00:00

New York Health Care Inc - Statement of Beneficial Ownership (SC 13D)

25/09/2008 12:11pm

Edgar (US Regulatory)


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13D-1(A)
AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(A)

New York Health Care, Inc.
(Name of Issuer)

Common Stock, $0.01 par value
(Title of Class of Securities)

649487204
(CUSIP Number)

David Polonitza
2550 Nelsonville Road, Boston, KY 40107
(502) 460-3141
(Name, Address and Telephone Number of the Person Authorized to
Receive Notices and Communications)

SEPTEMBER 25, 2008
(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f), or Rule 13d-1(g), check the following box |X|.

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


CUSIP No. 649487204 Schedule 13D Page 2 of 12

--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON

 David and Rebecka Polonitza Jt Ten
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 (a) |X|
 (b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY


--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*

 PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) OR 2(e) |_|


--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION

 United States of America
--------------------------------------------------------------------------------
 7 SOLE VOTING POWER

 1,170,466
 -----------------------------------------------------------------
 NUMBER OF 8 SHARED VOTING POWER
 SHARES
BENEFICIALLY 0
 OWNED BY -----------------------------------------------------------------
 EACH 9 SOLE DISPOSITIVE POWER
 REPORTING
 PERSON 1,170,466
 WITH -----------------------------------------------------------------
 10 SHARED DISPOSITIVE POWER

 0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,170,466
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|


--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 3.49%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*

 IN
--------------------------------------------------------------------------------
 *SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 649487204 Schedule 13D Page 3 of 12

--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON

 Kirk Anderson
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 (a) |X|
 (b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY


--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*

 PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) OR 2(e) |_|


--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION

 United States of America
--------------------------------------------------------------------------------
 7 SOLE VOTING POWER

 120,385
 -----------------------------------------------------------------
 NUMBER OF 8 SHARED VOTING POWER
 SHARES
BENEFICIALLY 0
 OWNED BY -----------------------------------------------------------------
 EACH 9 SOLE DISPOSITIVE POWER
 REPORTING
 PERSON 120,385
 WITH -----------------------------------------------------------------
 10 SHARED DISPOSITIVE POWER

 0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 120,385
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|


--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 0.35%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*

 IN
--------------------------------------------------------------------------------
 *SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 649487204 Schedule 13D Page 4 of 12

--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON

 Richard and Greta Polonitza Jt Ten
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 (a) |X|
 (b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY


--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*

 PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) OR 2(e) |_|


--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION

 United States of America
--------------------------------------------------------------------------------
 7 SOLE VOTING POWER

 84,391
 -----------------------------------------------------------------
 NUMBER OF 8 SHARED VOTING POWER
 SHARES
BENEFICIALLY 0
 OWNED BY -----------------------------------------------------------------
 EACH 9 SOLE DISPOSITIVE POWER
 REPORTING
 PERSON 84,391
 WITH -----------------------------------------------------------------
 10 SHARED DISPOSITIVE POWER

 0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 84,391
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|


--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 0.25%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*

 IN
--------------------------------------------------------------------------------
 *SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 649487204 Schedule 13D Page 5 of 12

--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON

 Ramero Roldan
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 (a) |X|
 (b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY


--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*

 PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) OR 2(e) |_|


--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION

 United States of America
--------------------------------------------------------------------------------
 7 SOLE VOTING POWER

 206,500
 -----------------------------------------------------------------
 NUMBER OF 8 SHARED VOTING POWER
 SHARES
BENEFICIALLY 0
 OWNED BY -----------------------------------------------------------------
 EACH 9 SOLE DISPOSITIVE POWER
 REPORTING
 PERSON 206,500
 WITH -----------------------------------------------------------------
 10 SHARED DISPOSITIVE POWER

 0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 206,500
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|


--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 0.62%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*

 IN
--------------------------------------------------------------------------------
 *SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 649487204 Schedule 13D Page 6 of 12

--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON

 Phyllis Anderson
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 (a) |X|
 (b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY


--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*

 PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) OR 2(e) |_|


--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION

 United States of America
--------------------------------------------------------------------------------
 7 SOLE VOTING POWER

 210,372
 -----------------------------------------------------------------
 NUMBER OF 8 SHARED VOTING POWER
 SHARES
BENEFICIALLY 0
 OWNED BY -----------------------------------------------------------------
 EACH 9 SOLE DISPOSITIVE POWER
 REPORTING
 PERSON 210,372
 WITH -----------------------------------------------------------------
 10 SHARED DISPOSITIVE POWER

 0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 210,372
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|


--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 0.62%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*

 IN
--------------------------------------------------------------------------------
 *SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 649487204 Schedule 13D Page 7 of 12

--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
 S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON

 Benjamin Polonitza
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 (a) |X|
 (b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY


--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*

 PF
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
 PURSUANT TO ITEMS 2(d) OR 2(e) |_|


--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION

 United States of America
--------------------------------------------------------------------------------
 7 SOLE VOTING POWER

 1,400
 -----------------------------------------------------------------
 NUMBER OF 8 SHARED VOTING POWER
 SHARES
BENEFICIALLY 0
 OWNED BY -----------------------------------------------------------------
 EACH 9 SOLE DISPOSITIVE POWER
 REPORTING
 PERSON 1,400
 WITH -----------------------------------------------------------------
 10 SHARED DISPOSITIVE POWER

 0
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 1,400
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|


--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 0.00%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*

 IN
--------------------------------------------------------------------------------
 *SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 649487204 Schedule 13D Page 8 of 12

Item 1. Security and Issuer

This Statement relates to shares of common stock, par value $.01 per share (the
"Common Stock"), of New York Health Care, Inc., a New York corporation (the
"Issuer" or "New York Health Care, Inc"). The Issuer's principal executive
offices of the Company is 1850 McDonald Avenue, Brooklyn, New York 11223.

Item 2. Identity and Background

(a)-(c), (f)

This Statement on Schedule 13D is being jointly filed by David Polonitza ("Mr.
D. Polonitza"), Rebecka Polonitza ("Mrs. R. Polonitza") Kirk Anderson ("Mr.
Anderson"), Paul Kim ("Mr. Kim"), Richard Polonitza ("Mr. R. Polonitza"), Greta
Polonitza ("Mrs. G. Polonitza"), Ramero Roldan ("Mr. Roldan"), Phyllis Anderson
("Mrs. Anderson"), and Benjamin Polonitza ("Mr. B. Polonitza") (each a
"Reporting Person" and, collectively, the "Reporting Persons" or "The Polonitza
Group").

David Polonitza and Rebecka Polonitza - Mr. D. Polonitza and Mrs. R. Polonitza's
current address is 2550 Nelsonville Road, Boston, Kentucky 40107. Mr. D.
Polonitza is a Captain in the United States Army and has been a member of the
military since 2002. Mr. D. Polonitza's current business address is 5935 Alcase
Street, Fort Knox, Kentucky 40121. Mr. D. Polonitza is the son of Mr. R. and
Mrs. G. Polonitza and brother of Mr. B. Polonitza. Mrs. R. Polonitza is
currently enrolled at the University of Louisville, Oppenheimer Hall,
Louisville, KY 40292. Mr. D. Polonitza and Mrs. R. Polonitza are citizens of the
United States

Kirk Anderson - Mr. Anderson's current business address is 9914 West Military
Drive #1323, San Antonio, Texas, 78251. Mr. Anderson is a self-employed Network
Engineering Consultant. Mr. Anderson is the son of Mrs. Anderson. Mr. Anderson
is a citizen of the United States.

Richard Polonitza and Greta Polonitza - Mr. R. Polonitza and Mrs. G. Polonitza's
current address is 23 Retford Avenue, Cranford, New Jersey, 07016. Mr. R.
Polonitza is retired. Mrs. G. Polonitza's principal occupation is as teacher at
Herbert Hoover Middle School, 174 Jackson Ave., Edison NJ 08837. Mr. R.
Polonitza and Mrs. G. Polonitza are the parents of Mr. D. Polonitza and Mr. B.
Polonitza. Mr. R. Polonitza and Mrs. G. Polonitza are citizens of the United
States.

Phyllis Anderson - Mrs. Anderson's current address is 2302 Blanton Drive, San
Antonio, TX 78209. Mrs. Anderson's is a substitute teacher primarily at St.
Andrews School, 722 Robinhood Place, San Antonio, TX 78209. Mrs. Anderson is the
mother of Mr. Anderson. Mrs. Anderson is a citizen of the United States.

Ramero Roldan - Mr. Roldan's current address is 420 Elmington Avenue, APT 1220,
Nashville, TN 37205. Mr. Roldan's principle occupation is an analyst of the
Asurion Corporation. Mr. Roldan's principal business address is 648 Grassmere
Park, Suite 300, Nashville, TN 37211. Mr. Roldan is a citizen of the United
States.

Mr. Benjamin Polonitza - Mr. B. Polonitza's current address is 23 Retford
Avenue, Cranford, New Jersey, 07016. Mr. B. Polonitza is


CUSIP No. 649487204 Schedule 13D Page 9 of 12

currently a student enrolled at Rutgers University, 57 US Highway 1, New
Brunswick, New Jersey, 08901. Mr. B. Polonitza is the son of Mr. R. and Mrs. G.
Polonitza and brother of Mr. D. Polonitza. Mr. B. Polonitza is a citizen of the
United States.

(d)-(e)

During the last five years, none of the Reporting Persons has been convicted in
a criminal proceeding (excluding traffic violations or similar misdemeanors) or
been a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, federal or state securities laws or finding
any violation with respect to such laws.

Item 3. Source and Amount of Funds or Other Consideration.

Each Reporting Person acquired his or her Common Stock currently held in either
a personal account of IRAs with personal funds. None of the securities have now
or ever been pledged for any loans nor used for other margin purposes. The total
cost for the Shares that the Reporting Persons may be deemed to beneficially own
is $171,929.

Item 4. Purpose of Transaction.

The Shares were acquired for investment purposes. However, The Reporting Persons
intend to evaluate the business prospects of the Issuer, as well as its present
and future intentions. In connection with such evaluation, the Reporting Persons
anticipate that they may in the future make suggestions and potentially have
discussions and other communications with the Issuer's management and possibly
other stockholders regarding matters in order to enhance the value of the
investment in the Issuer's Common Stock through one of the following
alternatives, but not limited to: a sale of the Issuer's stake in BioBalance
LLC, a spinoff of the Issuer's 66-2/3% BioBalance LLC to existing shareholders
in conjunction with a rights offering for BioBalance LLC shareholders, the
halting of addition funding by New York Health Care, Inc. to BioBalance LLC if a
strategic partner or investor is not found.

The Reporting Persons also intend to examine the past and present relationship
of members of the Issuer's board of directors and Mr. Yitzchok Grossman ("Mr.
Grossman"). Mr. Grossman is currently a 33-1/3% beneficial owner and paid
consultant of BioBalance LLC, as set forth in the Form 10-Q and related
documents filed by the Issuer with the Securities and Exchange Commission
("SEC") on August 14, 2008. It is the Reporting Persons' opinion that Mr.
Grossman's continued involvement with BioBalance LLC and the Issuer could create
future obstacles in obtaining a suitable strategic partner or investor in
BioBalance LLC due to Mr. Grossman's past legal troubles, which were cited in
November 26, 2003 press release issued by the Issuer and later documented within
a December 11, 2003 8-K filing with the SEC by the Issuer.


CUSIP No. 649487204 Schedule 13D Page 10 of 12

The Reporting Persons, individually or collectively, may request representation on the board of directors, seek to participate in, and influence the outcome of the Shareholders Meeting, including recommending or nominating a partial or entire slate of directors and participating in any proxy solicitation for the Shareholders Meeting. Depending upon the foregoing factors and to the extent deemed advisable in light of their general investment policies, or other factors, the Reporting Persons may formulate other purposes, plans or proposals regarding the Issuer or the Shares. The foregoing is subject to change at any time, and there can be no assurance that any of the Reporting Persons will take any of the actions set forth above.

The Reporting Persons may effect transactions that would change the number of shares they may be deemed to own beneficially.

Except as described above, none of the Reporting Persons has any plans or proposals which relate to or would result in any of the actions described in Item 4(a)-(j).

Item 5. Interest in Securities of the Issuer.

(a)-(b). As of September 25th 2008, the aggregate number of shares of Common Stock and percentage of the outstanding Common Stock of the Issuer beneficially owned (i) by each of the Reporting Persons, and (ii) to the knowledge of the Reporting Persons, by each other person who may be deemed to be a member of a group, is as follows:

 Aggregate Number of Shares: Number of Shares:
 Reporting Number of Sole Power to Vote Shared Power to Percentage*
 Person Shares or Dispose Vote or Dispose Approximate
----------------------------------------------------------------------------------------------------
David and Rebecka
 Polonitza 1,170,466 1,170,466 0 3.49%
----------------------------------------------------------------------------------------------------
 Kirk Anderson 120,385 120,385 0 0.35%
----------------------------------------------------------------------------------------------------
 Richard and Greta
 Polonitza 84,391 84,391 0 0.25%
----------------------------------------------------------------------------------------------------
 Ramero Roldan 206,500 206,500 0 0.62%
----------------------------------------------------------------------------------------------------
 Phyllis Anderson 210,372 210,372 0 0.62%
----------------------------------------------------------------------------------------------------
 Benjamin Polonitza 1,400 1,400 0 0.00%
----------------------------------------------------------------------------------------------------
 Total 1,793,514 1,793,514 0 5.34%
----------------------------------------------------------------------------------------------------

*Based on 33,536,767 shares of Common Stock, Par Value $0.01 per share, outstanding pursuant to the Issuer's Form 10Q filed with the Securities and Exchange Commission on August 14, 2008, for the quarter ended June 30, 2008.


CUSIP No. 649487204 Schedule 13D Page 11 of 12

The Reporting Persons have verbally agreed and intend to vote any proxies or act on any shareholder matters as one group. No member of the group has the power or right to vote or dispose of the shares of any other member of the group.

c) The table below lists all the transactions in the Issuer's Common Stock in the last sixty days by the Reporting Persons. All transactions were made in the open market.

Transactions in Common Stock Within the Past Sixty Days

 Date of Number of Shares of
 Party Purchase/ Sale the Common Stock Buy/Sell Price Per Share
Mr. D. and
Mrs. R. Polonitza 9/3/2008 100000 Buy $0.08
 9/3/2008 46063 Buy $0.08
 9/8/2008 30000 Buy $0.07
 9/8/2008 25000 Buy $0.07
 9/8/2008 13887 Buy $0.08
 9/8/2008 5000 Buy $0.08
 9/8/2008 71000 Buy $0.08
 9/9/2008 40000 Buy $0.07
 9/10/2008 95000 Buy $0.07
 9/10/2008 50000 Buy $0.07
 9/11/2008 21965 Buy $0.07
 9/12/2008 42000 Buy $0.075
 9/12/2008 26000 Buy $0.075
 9/12/2008 5000 Buy $0.075
 9/16/2008 23000 Buy $0.065
Mr. Anderson 9/23/2008 1400 Buy $0.065
Mr. D. and
Mrs. R. Polonitza 9/23/2008 600 Buy $0.065

Mr. R. and
Mrs. G. Polonitza 9/23/2008 45000 Buy $0.065
Mr. R. and
Mrs. G. Polonitza 9/24/2008 1576 Buy $0.075

(d) No Person other than the Reporting Persons is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such shares of Common Stock beneficially owned by the Reporting Persons.

(e) Not Applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Except as set forth in Item 4, above, and the Reporting Persons' verbal agreement to work together as a group as discussed herein and the Joint Filing Agreement among and between the Reporting Persons (filed


CUSIP No. 649487204 Schedule 13D Page 12 of 12

herewith), there are no contracts, arrangements, understandings or relationships
(legal or otherwise) among the Reporting Persons, or between the Reporting
Persons and any person, with respect to any securities of the Issuer, including
but not limited to transfer or voting of any of such securities, finders' fees,
joint ventures, loan or option arrangements, puts or calls, guarantees of
profits, division of profits or loss or the giving or withholding of proxies.


Item 7. Materials To Be Filed As Exhibits


The following documents are filed as exhibits hereto and are incorporated herein
by reference:


Exhibit 99.1 Joint Filing Agreement dated September 25, 2008 among and between
 the Reporting Persons

 SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.


Date: September 25, 2008 By: /s/ David Polonitza
 -------------------------------
 Name: David Polonitza

Date: September 25, 2008 By: /s/ Rebecka Polonitza
 -------------------------------
 Name: Rebecka Polonitza

Date: September 25, 2008 By: /s/ Kirk Anderson
 -------------------------------
 Name: Kirk Anderson

Date: September 25, 2008 By: /s/ Richard Polonitza
 -------------------------------
 Name: Richard Polonitza

Date: September 25, 2008 By: /s/ Greta Polonitza
 -------------------------------
 Name: Greta Polonitza

Date: September 25, 2008 By: /s/ Ramero Roldan
 -------------------------------
 Name: Ramero Roldan

Date: September 25, 2008 By: /s/ Phyllis Anderson
 -------------------------------
 Name: Phyllis Anderson


Date: September 25, 2008 By: /s/ Benjamin Polonitza
 -------------------------------
 Name: Benjamin Polonitza

1 Year New York Health Care (CE) Chart

1 Year New York Health Care (CE) Chart

1 Month New York Health Care (CE) Chart

1 Month New York Health Care (CE) Chart